MALAT1 and neoplasm: Meanwhile, MALAT1 caused tumor cell infiltration and drug resistance in glioblastoma multiforme (GBM), combining standard TMZ treatment with targeted nanocomplex carrying siRNA against MALAT1 substantially enhanced the very poor prognosis for GBM patients [28].